These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6413678)

  • 21. Percutaneous nitroglycerin absorption in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1979 May; 68(5):608-12. PubMed ID: 107313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transdermal nitroglycerin preparations in angina pectoris].
    Evald T; Svendsen TL; Kampmann JP
    Ugeskr Laeger; 1986 Feb; 148(6):335-8. PubMed ID: 3082056
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro.
    Loftsson T; Somogyi G; Bodor N
    Acta Pharm Nord; 1989; 1(5):279-86. PubMed ID: 2514720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative in vitro study of transdermal absorption of antiemetics.
    Calpena AC; Blanes C; Moreno J; Obach R; Domenech J
    J Pharm Sci; 1994 Jan; 83(1):29-33. PubMed ID: 8138905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of various marine lipids on transdermal drug delivery--in vitro evaluation.
    Loftsson T; Gunnarsdóttir T; Magnúsdóttir LM; Frioriksdóttir H; Guomundsdóttir TK; Olafsson JH; Haraldsson GG; Guomundsson G; Hjaltason B
    Boll Chim Farm; 1997 Nov; 136(10):640-5. PubMed ID: 9528172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.
    Centkowska K; Sznitowska M
    J Pharm Pharmacol; 2013 Oct; 65(10):1463-72. PubMed ID: 24028613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal drug delivery systems of albuterol: in vitro and in vivo studies.
    Gokhale R; Schmidt C; Alcorn L; Stolzenbach J; Schoenhard G; Farhadieh B; Needham T
    J Pharm Sci; 1992 Oct; 81(10):996-9. PubMed ID: 1432626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
    Moe G; Armstrong PW
    Am J Med; 1986 Nov; 81(5):765-70. PubMed ID: 3096133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of formulating factors on drug safety of timed-release nitroglycerin tablets.
    Ritschel WA
    J Pharm Sci; 1971 Nov; 60(11):1683-5. PubMed ID: 5002527
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
    Choi A; Gang H; Chun I; Gwak H
    Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a transdermal patch of methadone: in vitro evaluation across hairless mouse and human cadaver skin.
    Ghosh TK; Bagherian A
    Pharm Dev Technol; 1996 Oct; 1(3):285-91. PubMed ID: 9552311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
    Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
    J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous absorption of nitroglycerin.
    Noonan PK; Wester RC
    J Pharm Sci; 1980 Mar; 69(3):365-6. PubMed ID: 6770072
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin (author's transl)].
    Garnier B; Imhof P; Spinelli F; Jost H
    Schweiz Rundsch Med Prax; 1982 Mar; 71(12):511-6. PubMed ID: 6806799
    [No Abstract]   [Full Text] [Related]  

  • 40. Performance of a new transdermal nitroglycerin adhesive patch formulation.
    Riedel DJ; Wick KA; Hawkinson RW; Kolars CA; Crowley JK; Armstrong KE; Chang SF; Harrison LI; de Dennis SR
    Clin Ther; 1989; 11(2):225-31. PubMed ID: 2500248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.